Supernus Pharmaceuticals Inc
SUPN
Market Cap$1.77B
Close$
$90.42
180.5% upside
Current Fair Value
180.5% upsideUndervalued by 180.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.77 Billion |
|---|---|
| Enterprise Value | $1.69 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.34 |
| Beta | 0.74 |
| Outstanding Shares | 55,864,692 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 28.6 |
|---|---|
| PEG | -0.3 |
| Price to Sales | 2.93 |
| Price to Book Ratio | 1.79 |
| Enterprise Value to Revenue | 2.53 |
| Enterprise Value to EBIT | 26.95 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Supernus Pharmaceuticals Inc
CEO: Jack Khattar